Abstract
Patients with a cancer at time of first venous thromboembolism (VTE) have not been thoroughly analyzed. Our study aimed to (1) determine the frequency of cancer diagnosed in patients hospitalized for a first VTE episode, (2) investigate the characteristics of VTE and cancer in such patients. All consecutive adults patients hospitalized over a 6-years period for a first VTE episode in a tertiary care hospital were considered. Patients with congenital or acquired thrombophilia were excluded. Demographic, medical history, and follow up data were retrieved from medical records. 216 patients (63.6 ± 19.7 years, 63.4 % females) hospitalized for a first VTE were analyzed. Among them, 64 patients (29.6 %) had cancer, either revealed (n = 26) or already known (n = 38) at VTE diagnosis. Cancer was in an advanced stage in 26 patients (40.6 %). Patients with cancer were older and displayed a higher frequency of vena cava thrombosis, as compared to patients without cancer. VTE was more recurrent and mortality was higher in patients with cancer. Cancer occurred after VTE diagnosis in only 2 (2/127, 1.6 %) cases during a protracted follow-up of 24.1 ± 22.5 months. Overall, VTE preceded cancer diagnosis in only 3 % (2/66) of cases. Frequency of cancer is high among patients hospitalized for a first VTE. In such setting, VTE often involved unusual sites such as vena cava. In most cases, cancer was either already known or diagnosed at time of VTE, with a poor prognosis.
Similar content being viewed by others
References
Otten HM, Prins MH (2001) Venous thromboembolism and occult malignancy. Thromb Res 102:V187–V194
Prandoni P, Lensing AW, Buller HR, Cogo A, Prins MH, Cattelan AM et al (1992) Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 327:1128–1133
Sorensen HT, Mellemkjaer L, Steffensen FH, Olsen JH, Nielsen GL (1998) The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 338:1169–1173
White RH, Chew HK, Zhou H, Parikh-Patel A, Harris D, Harvey D et al (2005) Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults. Arch Intern Med 165:1782–1787
Baron JA, Gridley G, Weiderpass E, Nyren O, Linet M (1998) Venous thromboembolism and cancer. Lancet 351:1077–1080
Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M et al (1996) The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 125:1–7
Murchison JT, Wylie L, Stockton DL (2004) Excess risk of cancer in patients with primary venous thromboembolism: a national, population-based cohort study. Br J Cancer 91:92–95
Prandoni P, Falanga A, Piccioli A (2005) Cancer and venous thromboembolism. Lancet Oncol. 6:401–410
Oudega R, Moons KG, Karel Nieuwenhuis H, van Nierop FL, Hoes AW (2006) Deep vein thrombosis in primary care: possible malignancy? Br J Gen Pract 56:693–696
Khorana AA, McCrae KR (2014) Risk stratification strategies for cancer-associated thrombosis: an update. Thromb Res 133:S35–S38
Blom JW, Doggen CJ, Osanto S, Rosendaal FR (2005) Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293:715–722
Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH (2007) Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 110:2339–2346
Khorana AA, Connolly GC (2009) Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol 27:4839–4847
Wun T, White RH (2009) Epidemiology of cancer-related venous thromboembolism. Best Pract Res Clin Haematol 22:9–23
Connolly GC, Menapace L, Safadjou S, Francis CW, Khorana AA (2013) Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients. Clin Lung Cancer. 14:713–718
Horsted F, West J, Grainge MJ (2012) Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med 9:e1001275
Monreal M, Lensing AW, Prins MH, Bonet M, Fernandez-Llamazares J, Muchart J et al (2004) Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism. J Thromb Haemost 2:876–881
Piccioli A, Lensing AW, Prins MH, Falanga A, Scannapieco GL, Ieran M et al (2004) Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial. J Thromb Haemost 2:884–889
Carrier M, Lazo-Langner A, Shivakumar S, Tagalakis V, Zarychanski R, Solymoss S et al (2015) Screening for occult cancer in unprovoked venous thromboembolism. N Engl J Med 373:697–704
Khorana AA, Rubens D, Francis CW (2014) Screening high-risk cancer patients for VTE: a prospective observational study. Thromb Res 134:1205–1207
Chauchard M, Benali K, Papo T, Sacre K (2014) Positron emission tomography combined with computed tomography as a screening tool for occult malignancy in patients with unprovoked venous thromboembolism: an observational study. Med (Baltim) 93:e110
Carrier M, Le Gal G, Wells PS, Fergusson D, Ramsay T, Rodger MA (2008) Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann Intern Med 149:323–333
Van Doormaal FF, Terpstra W, Van Der Griend R, Prins MH, Nijziel MR, Van De Ree MA et al (2011) Is extensive screening for cancer in idiopathic venous thromboembolism warranted? J Thromb Haemost 9:79–84
Prandoni P, Casiglia E, Piccioli A, Ghirarduzzi A, Pengo V, Gu C et al (2010) The risk of cancer in patients with venous thromboembolism does not exceed that expected in the general population after the first 6 months. J Thromb Haemost 8:1126–1127
Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343:1846–1850
Chew HK, Wun T, Harvey D, Zhou H, White RH (2006) Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 166:458–464
Nordstrom M, Lindblad B, Anderson H, Bergqvist D, Kjellstrom T (1994) Deep venous thrombosis and occult malignancy: an epidemiological study. BMJ 308:891–894
Hettiarachchi RJ, Lok J, Prins MH, Buller HR, Prandoni P (1998) Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk indicators, and diagnosis. Cancer 83:180–185
Rance A, Emmerich J, Guedj C, Fiessinger JN (1997) Occult cancer in patients with bilateral deep-vein thrombosis. Lancet 350:1448–1449
Acknowledgments
The authors thank Drs MP Chauveheid, C. Compain, D. Gobert, C. Gorgiard, R Jouenne, D Lariviere, O. Lidove, and E. Pasqualoni for their help with patients’ screening. This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The authors declare that they have no conflict of interest.
Research Involving Human Participants
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (Institutional Review Board of HUPNVS, Paris 7 University, AP-HP) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For retrospective studies, formal consent is not required.
Informed Consent
Because of the retrospective nature of the study, the review board waived the need for written informed consent from the patients. Patients were however informed that data collected in medical records might be used for research study in accordance to privacy rule.
Rights and permissions
About this article
Cite this article
Rouzaud, D., Alexandra, JF., Chauchard, M. et al. Frequency of malignancy is high in patients admitted for a first venous thromboembolism episode: an observational study. J Thromb Thrombolysis 42, 329–335 (2016). https://doi.org/10.1007/s11239-016-1355-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-016-1355-2